Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-024245

Senior VP & General Counsel gave up 3,674 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kim Mina Senior VP & General Counsel 2019-04-09 Shares withheld for taxes −3,674 $36.85 $135,387 66,389 D
Loading xslF345X03/doc4.xml…